期刊文献+

N-(2,6-二甲苯基)-2-(1-哌嗪基)乙酰胺纯化工艺研究

Study on the Purification Process of N-(2,6-dimethylphenyl)-2-(piperazin-1-yl)acetamide
下载PDF
导出
摘要 N-(2,6-二甲苯基)-2-(1-哌嗪基)乙酰胺合成过程中,会同时有产品及哌嗪双取代副产物生成,通过研究两者在常规溶剂中的溶解度,利用溶解度差异,选用乙醇对产品进行纯化,革除了原有不适于工业化规模生产的乙醚重结晶纯化工艺。 The disubstitution byproduct would be synthesized at the same time during the synthesis process of N-(2,6-dimethylphenyl)-2-(piperazin-l-yl) acetamide. The paper pays more attention to the study of the solubility between them in different common solvents. Successfully get rid of the process of using ether to recrystallize with purifying the product by using ethanol instead.
出处 《上海化工》 CAS 2009年第4期4-5,共2页 Shanghai Chemical Industry
关键词 N-(2 6-二甲苯基)-2-(1-哌嗪基)乙酰胺 雷诺嗪中间体 纯化工艺 N-(2,6-dimethylphenyl)-2-(piperazin-l-yl) acetamide Intermediate of Ranolazine Purification process
  • 相关文献

参考文献7

二级参考文献22

  • 1唐家荣,韩静,侯凌波.教学医院及职工医院高血压患者用药情况调查分析[J].药物流行病学杂志,2005,14(4):229-232. 被引量:2
  • 2韩静.我院门诊抗高血压药的使用分析[J].中国药师,2005,8(11):962-963. 被引量:8
  • 3陈明宝,向道康.新型调节心肌代谢药物雷诺嗪的研究进展[J].贵州医药,2006,30(1):89-91. 被引量:1
  • 4Eva AC, Tibor G, Kalman H. Process for the preparation of piperazine derivatives [ P]. EP: 0483932 A1,1991 - 10- 31.
  • 5McCormack JG, Stanley WC, Wolff AA. Ranolazine, a novel metabolic modulator for the treatment of angina[J]. Gen Pharm, 1998, 30(5) :639 - 645.
  • 6Zacharowski K, Lackburn BB, Thiemeermann C. Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat [ J ]. Eur J Pharmacol, 2001, 418 (1 - 2) : 105 -110.
  • 7Mcaroon J, Clark RD, Kluge AF, et al. Synthesis and antihypertensive activity of a series of 8-aubalituted 1-oxa-3, 8-diazaspiro [ 4. 5 ] decan-2-ones [ J ]. J Med Chem, 1981,24(11) : 1320 - 1328.
  • 8Kluge AF, Clark RD, Strosberg AM, et al. Cardioselective aryloxy-and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry[P]. US:4567264,1986 - 01 - 28.
  • 9Chandler MP,Sztanley WC,Morita H,et al.Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart fail-ure[J].Cric Res,2002,91(4):278
  • 10Zacharowski K,Blackburn B,Thienmermann C.Ranolazine,a partial fatty acid oxidation inhibitor,reduce myocardialinfarct size and cardic troponin T release in the rat[J].Eur J Pharmacol,2001,418(1-2):105

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部